Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
Nishida T, Kobayashi T, Sawa M, Masuda S, Shibasaki Y, Goto T, Fukuhara N, Fujii N, Ikegame K, Sugita J, Ikeda T, Kuwatsuka Y, Suzuki R, Najima Y, Doki N, Kato T, Inagaki Y, Utsu Y, Aotsuka N, Masuko M, Terakura S, Onishi Y, Maeda Y, Okada M, Teshima T, Murata M. Nishida T, et al. Among authors: sugita j. Ann Hematol. 2021 Mar;100(3):743-752. doi: 10.1007/s00277-020-04365-z. Epub 2021 Jan 11. Ann Hematol. 2021. PMID: 33427909 Clinical Trial.
Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma.
Toubai T, Hirate D, Shono Y, Ota S, Ibata M, Mashiko S, Sugita J, Shigematsu A, Miura Y, Kato N, Umehara S, Kahata K, Tsutsumi Y, Iwao N, Toyoshima N, Tanaka J, Asaka M, Imamura M. Toubai T, et al. Among authors: sugita j. Int J Lab Hematol. 2008 Feb;30(1):75-81. doi: 10.1111/j.1751-553X.2007.00903.x. Int J Lab Hematol. 2008. PMID: 18190473
Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation.
Kondo T, Yasumoto A, Arita K, Sugita J, Shigematsu A, Okada K, Takahata M, Onozawa M, Kahata K, Takeda Y, Obara M, Yamamoto S, Endo T, Nishio M, Sato N, Tanaka J, Hashino S, Koike T, Asaka M, Imamura M. Kondo T, et al. Among authors: sugita j. Int J Hematol. 2010 Mar;91(2):310-21. doi: 10.1007/s12185-009-0487-y. Epub 2010 Jan 20. Int J Hematol. 2010. PMID: 20087795 Free article.
Increased risk of bacterial infection after engraftment in patients treated with allogeneic bone marrow transplantation following reduced-intensity conditioning regimen.
Shigematsu A, Yamamoto S, Sugita J, Kondo T, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Yamaguchi K, Wakasa K, Takahata M, Goto H, Ito S, Takemura R, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Shigematsu A, et al. Among authors: sugita j. Transpl Infect Dis. 2010 Oct;12(5):412-20. doi: 10.1111/j.1399-3062.2010.00560.x. Epub 2010 Aug 24. Transpl Infect Dis. 2010. PMID: 20738830
Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia.
Arita K, Kondo T, Sugita J, Shigematsu A, Shiratori S, Wakasa K, Yasumoto A, Ibata M, Shono Y, Kikuchi M, Goto H, Takeda Y, Takahata M, Kato N, Nishio M, Ota S, Tanaka J, Imamura M. Arita K, et al. Among authors: sugita j. Int J Hematol. 2011 Sep;94(3):291-295. doi: 10.1007/s12185-011-0919-3. Epub 2011 Aug 31. Int J Hematol. 2011. PMID: 21879292 Free article.
[Upfront of prophylaxis and treatment of GVHD].
Sugita J, Teshima T. Sugita J, et al. Rinsho Ketsueki. 2013 Feb;54(2):156-66. Rinsho Ketsueki. 2013. PMID: 23470822 Review. Japanese. No abstract available.
192 results